<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-pathogens-08-00168">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schotsaert</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Garcia-Sastre</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Inactivated influenza virus vaccines: The future of TIV and QIV</article-title>
  <source>Curr. Opin. Virol.</source>
  <year>2017</year>
  <volume>23</volume>
  <fpage>102</fpage>
  <lpage>106</lpage>
  <pub-id pub-id-type="doi">10.1016/j.coviro.2017.04.005</pub-id>
  <?supplied-pmid 28505524?>
  <pub-id pub-id-type="pmid">28505524</pub-id>
 </element-citation>
</ref>
